Sai-Wen Tang

1.5k total citations
27 papers, 1.1k citations indexed

About

Sai-Wen Tang is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Sai-Wen Tang has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 14 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in Sai-Wen Tang's work include CAR-T cell therapy research (11 papers), Immune Cell Function and Interaction (6 papers) and Renal and related cancers (4 papers). Sai-Wen Tang is often cited by papers focused on CAR-T cell therapy research (11 papers), Immune Cell Function and Interaction (6 papers) and Renal and related cancers (4 papers). Sai-Wen Tang collaborates with scholars based in United States, Taiwan and Italy. Sai-Wen Tang's co-authors include Yves Pommier, Junko Murai, Jung‐Yaw Lin, Ming‐Kuen Lai, Wei‐Chou Lin, Ying Feng, Guoying Karen Yu, Yuqiao Shen, Yuanbin Ru and Vinodh N. Rajapakse and has published in prestigious journals such as Blood, Molecular Cell and The Journal of Immunology.

In The Last Decade

Sai-Wen Tang

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sai-Wen Tang United States 15 698 598 229 145 127 27 1.1k
Lopamudra Das Roy United States 16 605 0.9× 599 1.0× 369 1.6× 203 1.4× 50 0.4× 31 1.1k
Christa Cerni Austria 16 664 1.0× 428 0.7× 260 1.1× 150 1.0× 138 1.1× 27 1.1k
Takahito Nakahara Japan 13 947 1.4× 496 0.8× 174 0.8× 109 0.8× 98 0.8× 21 1.2k
Liya Ding United States 15 831 1.2× 468 0.8× 394 1.7× 342 2.4× 42 0.3× 21 1.3k
Laura Tamblyn Canada 16 999 1.4× 496 0.8× 352 1.5× 250 1.7× 122 1.0× 22 1.6k
Ukhyun Jo United States 20 782 1.1× 458 0.8× 71 0.3× 148 1.0× 51 0.4× 44 984
Coral Ampurdanés Spain 14 480 0.7× 534 0.9× 191 0.8× 88 0.6× 60 0.5× 19 888
Florine Obrist France 14 449 0.6× 335 0.6× 178 0.8× 145 1.0× 162 1.3× 16 842
Catherine J. Huntoon United States 22 857 1.2× 536 0.9× 386 1.7× 234 1.6× 77 0.6× 30 1.4k
Kálman G. Büki United States 20 714 1.0× 559 0.9× 211 0.9× 111 0.8× 58 0.5× 44 1.1k

Countries citing papers authored by Sai-Wen Tang

Since Specialization
Citations

This map shows the geographic impact of Sai-Wen Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sai-Wen Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sai-Wen Tang more than expected).

Fields of papers citing papers by Sai-Wen Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sai-Wen Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sai-Wen Tang. The network helps show where Sai-Wen Tang may publish in the future.

Co-authorship network of co-authors of Sai-Wen Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Sai-Wen Tang. A scholar is included among the top collaborators of Sai-Wen Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sai-Wen Tang. Sai-Wen Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lin, Yanliang, et al.. (2023). A Novel Allogeneic Rituximab-Conjugated Gamma Delta T Cell Therapy for the Treatment of Relapsed/Refractory B-Cell Lymphoma. Cancers. 15(19). 4844–4844. 5 indexed citations
3.
Lin, Yanliang, et al.. (2023). Abstract LB089: ACE2016: an off-the-shelf EGFR-targeting γδ2 T cell therapy against EGFR-expressing solid tumors. Cancer Research. 83(8_Supplement). LB089–LB089. 2 indexed citations
4.
Pérez-Cruz, Magdiel, Bettina P. Iliopoulou, Hsin‐Hsu Wu, et al.. (2022). Immunoregulatory effects of RGMb in gut inflammation. Frontiers in Immunology. 13. 960329–960329. 8 indexed citations
5.
Tang, Sai-Wen, et al.. (2021). A novel endogenous CD16-Expressing Natural Killer Cell for cancer immunotherapy. Biochemistry and Biophysics Reports. 26. 100935–100935. 13 indexed citations
7.
Frank, Matthew J., Niclas Olsson, Andy Huang, et al.. (2020). A novel antibody-cell conjugation method to enhance and characterize cytokine-induced killer cells. Cytotherapy. 22(3). 135–143. 18 indexed citations
8.
Kaur, Sukhbir, Anthony L. Schwartz, David R. Soto‐Pantoja, et al.. (2019). Identification of Schlafen-11 as a Target of CD47 Signaling That Regulates Sensitivity to Ionizing Radiation and Topoisomerase Inhibitors. Frontiers in Oncology. 9. 994–994. 24 indexed citations
9.
Tang, Sai-Wen, Anish Thomas, Junko Murai, et al.. (2018). Overcoming Resistance to DNA-Targeted Agents by Epigenetic Activation of Schlafen 11 ( SLFN11) Expression with Class I Histone Deacetylase Inhibitors. Clinical Cancer Research. 24(8). 1944–1953. 65 indexed citations
10.
Murai, Junko, Sai-Wen Tang, Elisabetta Leo, et al.. (2018). SLFN11 Blocks Stressed Replication Forks Independently of ATR. Molecular Cell. 69(3). 371–384.e6. 182 indexed citations
11.
Frank, Matthew J., Andy Huang, Sai-Wen Tang, et al.. (2017). A Novel Antibody-Cell Conjugation Method to Enhance Cellular Therapies for the Treatment of Hematological Malignancies. Blood. 130. 1532–1532. 1 indexed citations
12.
Liu, Yu-Huei, et al.. (2017). Aqueous extract of Polygonum bistorta modulates proteostasis by ROS-induced ER stress in human hepatoma cells. Scientific Reports. 7(1). 41437–41437. 27 indexed citations
13.
Pierini, Antonio, Bettina P. Iliopoulou, Heshan Peiris, et al.. (2017). T cells expressing chimeric antigen receptor promote immune tolerance. JCI Insight. 2(20). 80 indexed citations
14.
Sousa, Fabrício G., Renata Matuo, Sai-Wen Tang, et al.. (2015). Alterations of DNA repair genes in the NCI-60 cell lines and their predictive value for anticancer drug activity. DNA repair. 28. 107–115. 43 indexed citations
15.
Tang, Sai-Wen, Aurélie Ducroux, Kuan‐Teh Jeang, & Christine Neuveut. (2012). Impact of cellular autophagy on viruses: Insights from hepatitis B virus and human retroviruses. Journal of Biomedical Science. 19(1). 92–92. 52 indexed citations
16.
Tang, Sai-Wen & Jung‐Yaw Lin. (2012). Full-Length Enrich c-DNA Libraries-Clear Cell-Renal Cell Carcinoma. Journal of Oncology. 2012. 1–15. 3 indexed citations
17.
Tang, Sai-Wen, Wei‐Chou Lin, Wen‐Hsin Chang, et al.. (2010). Nicotinamide N -methyltransferase induces cellular invasion through activating matrix metalloproteinase-2 expression in clear cell renal cell carcinoma cells. Carcinogenesis. 32(2). 138–145. 117 indexed citations
18.
Tang, Sai-Wen, Wen-Hsin Chang, Yu‐Chi Chen, et al.. (2008). MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells. Cancer Letters. 273(1). 35–43. 112 indexed citations
19.
20.
Tang, Sai-Wen, Wen‐Hsin Chang, Yu‐Chi Chen, et al.. (2006). Identification of differentially expressed genes in clear cell renal cell carcinoma by analysis of full-length enriched cDNA library. Journal of Biomedical Science. 13(2). 233–240. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026